Delivery Order SPE2DB22D1106-SPE2DB24FFLN1

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,537.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of July 1, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $2,510.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,275.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of the medication "XULANE 150-35 MCG/DAY PATCH 3S" and has an ultimate completion date of December 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,723.16 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medication used in contraception. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,254.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract is a delivery order with a firm fixed price, valued at $2,980.32, and has an ultimate completion date of August 28, 2024. This contract is not associated with a set-aside program. As a significant supplier of pharmaceutical and medical products to various federal...
This federal contract award, valued at $15,075.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a type of prescription contraceptive patch. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2024. This award is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.82 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,202.78, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April...
This federal contract award, valued at $1,974.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of March 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLN1
    Delivery Order

This federal contract award, valued at $1,797.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of September 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 12/6/24, 9:25 AM